Targeting mitochondrial oxidative metabolism as an approach to treat heart failure
- 30 April 2013
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1833 (4), 857-865
- https://doi.org/10.1016/j.bbamcr.2012.08.014
Abstract
No abstract availableFunding Information
- Heart and Stroke Foundation of Alberta
This publication has 120 references indexed in Scilit:
- A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila , and HumansScience, 2012
- Identification and Functional Expression of the Mitochondrial Pyruvate CarrierScience, 2012
- Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trialEuropean Heart Journal, 2010
- Cellular fatty acid uptake: a pathway under constructionTrends in Endocrinology & Metabolism, 2009
- Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Reverse changes in cardiac substrate oxidation in dogs recovering from heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnoverJournal of Molecular and Cellular Cardiology, 2008
- Defective Fatty Acid Uptake in the Spontaneously Hypertensive Rat Is a Primary Determinant of Altered Glucose Metabolism, Hyperinsulinemia, and Myocardial HypertrophyOnline Journal of Public Health Informatics, 2001
- Less Extrahepatic Induction of Fatty Acid β-Oxidation Enzymes by PPARαBiochemical and Biophysical Research Communications, 2000
- Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989